Fate Therapeutics, Inc. (FATE) vs Treace Medical Concepts, Inc. (TMCI)

A side-by-side comparison of Fate Therapeutics, Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FATE vs TMCI

growth of $100 · dividends reinvested · last 5y
FATE -96.9% (-50.1%/yr)TMCI -82.5% (-29.4%/yr)TMCI compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$3$18
FATE TMCI

FATE vs TMCI: by the numbers

  • •FATE is the larger company ($271M vs $271M market cap).
  • •Both run net losses; TMCI's is the smaller (-28.99% vs -1941.09% net margin).
  • •TMCI grew revenue faster over the past five years (21.44% vs -32.98% CAGR).

Metrics side by side

Valuation

MetricFATETMCI
P/S ratio41.751.32
P/B ratio1.773.99

Profitability

MetricFATETMCI
Gross margin-94.12%79.45%
Operating margin-2222.45%-26.17%
Net margin-1941.09%-28.99%
ROE-82.12%-87.86%
ROIC-58.72%-37.64%

Growth (annualized)

MetricFATETMCI
Revenue CAGR (5Y)-32.98%21.44%
Total return CAGR (5Y)-46.86%-29.41%

Frequently asked

Which has grown faster, FATE or TMCI?
Over the past five years, TMCI grew revenue faster — FATE at a -32.98% CAGR versus TMCI at 21.44%.
How have FATE and TMCI total returns compared?
Over the past 5 years, FATE delivered -46.86% and TMCI delivered -29.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.